New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
1.0 Credit / Neurology
View More
Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis
1.5 Credits / Gastroenterology
View More
Assessing Utility of Anti-Vascular Endothelial Growth Factor Therapies in Retinal Disease: The Pharmacist’s Ro...
1.5 Credits / Ophthalmology/Optometry
View More
Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intrav...
1.0 Credit / Immunology, Rare Diseases
View More
Maximizing the Potential of Biologics in Moderate to Severe Pediatric Atopic Dermatitis: The Expertise of the ...
1.0 Credit / Dermatology, Immunology
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccin...
1.25 Credits / Immunization, Infectious Diseases
View More
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Care...
1.5 Credits / Neurology
View More
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
1.5 Credits / Allergy, Immunology
View More
Inotuzumab Ozogamicin in Pediatric Patients With Relapsed or Refractory B-Cell ALL
October 18th 2024This review discusses the significance of the FDA-approved drug inotuzumab ozogamicin in pediatric patients with acute lymphocytic leukemia (ALL) and relapsed/refractory (R/R) ALL, and the evolving therapeutic options in R/R ALL.
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma
October 17th 2024This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.